Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 120, Issue 3, 2000, Pages 478-489

  Luciani, Giovanni Battista ^a   Montalbano, Giuseppe ^a   Casali, Gianluca ^a   Mazzucco, Alessandro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0033865494     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2000.108692     Document Type: Article

References (33)

1. Donor availability as the primary determinant of the future of heart transplantation
2. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy
3. High-risk reparative surgery: A neglected alternative to heart transplantation
4. High-risk heart surgery in the heart transplant candidate
5. Ischemic cardiomyopathy: Criteria for coronary revascularization and cardiac transplantation
6. Severe ischemic left ventricular failure: Coronary operation or heart transplantation
7. The hibernating myocardium
8. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
9. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with rejection and PET imaging with 18F-flourodeoxyglucose
10. Coronary artery bypass grafting in patients with an ejection fraction of twenty or less
11. Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization
12. Prediction of outcome after revascularization in patients with poor left ventricular function
13. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction
14. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive failure
15. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage
16. Management of heart failure. III. The role of myocardial revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction
17. Coronary artery bypass grafting in patients with poor left ventricular function
18. Predicting survival after coronary revascularization for ischemic cardiomyopathy
19. Protection in the failing heart
20. Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction
21. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions
22. The importance of completeness of revascularization during long-term follow-up after coronary artery operations
23. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional status
24. Results of surgical revascularization in ischemic heart failure without angina
25. Coronary artery bypass surgery as treatment for ischemic heart failure: The predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome
26. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography
27. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability
28. First cardiological or cardiosurgical reintervention for ischemic heart disease after primary coronary artery bypass grafting
29. The risks of reoperative coronary artery bypass in chronic ischemic cardiomyopathy: Results of the CABG Patch Trial
30. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy
31. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events
32. Comparison of myocardial revascularization without cardiopulmonary bypass to standard open-heart technique in patients with left ventricular dysfunction
33. Comparative reproducibility and validity of systems foe assessing cardiovascular functional class: Advantages of a new specific activity scale